Biotech Stock Roundup: GSK’s Drug Approval, MRNA’s Vaccine News, PTCT & SPRY Down

Biotech Stock Roundup: GSK’s Drug Approval, MRNA’s Vaccine News, PTCT & SPRY Down

Upworthy

Published

It was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates. Among these, regulatory updates from GSK plc GSK and Moderna MRNA grabbed the spotlight. Recap of the Week’s Most Important Stories: GSK Blood Cancer Drug Approval: GSK obtained FDA approval for…

#gskplc #gsk #moderna #fda #jak1jak2 #splenomegaly #momentum #europeancommission #healthcare #pfizer

Full Article